These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3373758)

  • 1. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; mucosal blood-flow improving agents].
    Shimakura S; Fukutomi H
    Nihon Rinsho; 1988 Jan; 46(1):55-63. PubMed ID: 3373758
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; tissue healing inducing drugs].
    Mori H; Sato H; Seki Y
    Nihon Rinsho; 1988 Jan; 46(1):50-4. PubMed ID: 3373757
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study on pathogenesis of gastric ulcer in patient with liver cirrhosis: with special reference to the gastric mucosal blood flow].
    Maeda T
    Fukuoka Igaku Zasshi; 1988 Aug; 79(8):636-46. PubMed ID: 3192152
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
    Sakai M
    Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
    Hoshina K; Yamazaki N; Takeshita T; Naruchi T
    Arzneimittelforschung; 1985; 35(2):493-7. PubMed ID: 3873243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of cimetidine and cetraxate in the treatment of peptic ulcer.
    Archimandritis A; Tjivras M; Alexiou A; Bougas S; Fertakis A
    J Clin Gastroenterol; 1991 Feb; 13(1):114-5. PubMed ID: 2007733
    [No Abstract]   [Full Text] [Related]  

  • 7. [Microcirculatory disorders in chronic erosions of the stomach].
    Maev IV; Kaziulin AN; Kucheriavyĭ IuA; Gadzhieva MG
    Klin Med (Mosk); 2003; 81(6):37-42. PubMed ID: 12875190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
    Arakawa T; Kobayashi K
    Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastroprotective and ulcer healing effects of solon, a synthetic flavonoid derivative of sophoradin.
    Konturek SJ; Mrzozowski T; Drozdowicz D; Pawlik W; Sendur R
    Hepatogastroenterology; 1987 Aug; 34(4):164-70. PubMed ID: 3478294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various problems on refractory peptic ulcers; progress of drug therapy and changes in the concept of peptic ulcer].
    Ishimori A; Kawamura T
    Nihon Rinsho; 1988 Jan; 46(1):146-51. PubMed ID: 3373747
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptic ulcer disease.
    Hawker P
    Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in clinical test methods on the protective function of the gastric mucosa; evaluation of mucosal epithelium blood flow by reflectance spectrophotometry].
    Sato N; Tsuji S; Kamada T
    Nihon Rinsho; 1988 Jan; 46(1):175-8. PubMed ID: 3373751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; ulcer-surface protective drugs].
    Tsukamoto Y; Nakazawa S
    Nihon Rinsho; 1988 Jan; 46(1):45-9. PubMed ID: 3373756
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microcirculation in gastric mucosa as related to its secretory activity in patients with peptic ulcer].
    Shcherbynina MB
    Lik Sprava; 2002; (5-6):24-6. PubMed ID: 12442513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of drug substances on the blood flow in the gastric mucosa in peptic ulcer].
    Malov IuS
    Voen Med Zh; 1980 Jan; (1):57-9. PubMed ID: 7376498
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress in clinical test methods on the protective function of the gastric mucosa; endoscopic measurement of mucosal blood flow].
    Murakami M; Kuen YJ; Inoue R; Inada M; Miyake T
    Nihon Rinsho; 1988 Jan; 46(1):169-74. PubMed ID: 3373750
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effect of prolonged oral administration of cetraxate hydrochloride on experimentally-induced intestinal metaplasia in Wistar rats.
    Tatsuta M; Yamamura H; Iishi H; Taniguchi H
    Arzneimittelforschung; 1987 Sep; 37(9):1045-8. PubMed ID: 3435599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disturbance of regional blood flow and activity of lipid peroxidation in recurrent ulcer and their drug correction].
    Tsimmerman IS; Mikhailovskaia LV
    Klin Med (Mosk); 1996; 74(4):31-4. PubMed ID: 8999148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; synergistic drugs for protective factors in peptic ulcer].
    Miyake T
    Nihon Rinsho; 1988 Jan; 46(1):79-83. PubMed ID: 3373760
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical problems in the treatment and physiopathology of drug-induced peptic ulcers].
    Kamata T; Kawano J
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):64-7. PubMed ID: 2022907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.